Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By activating these https://poppiejjgq511443.link4blogs.com/57226802/tirzepatide-a-promising-new-treatment-for-obesity